Carillon Tower Advisers Views McKesson Corporation (MCK) as a Safe Investment

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. The second quarter witnessed a poor overall performance of mid-cap stocks. The Russell Midcap Growth Index was down 21.07% and fell more compared to its counterpart Russell Midcap Value Index (down 14.68%). In the quarter, all sector returns were negative for the Russell Midcap Growth Index due to market volatility. In addition, you can check the top 5 holdings of the fund to know its best picks in 2022.

Carillon Tower Advisers discussed stocks like McKesson Corporation (NYSE:MCK) in its second quarter 2022 investor letter. Headquartered in Irving, Texas, McKesson Corporation (NYSE:MCK) is a healthcare services providing company. On September 2, 2022, McKesson Corporation (NYSE:MCK) stock closed at $363.82 per share. One-month return of McKesson Corporation (NYSE:MCK) was 4.73% and its shares gained 76.37% of their value over the last 52 weeks. McKesson Corporation (NYSE:MCK) has a market capitalization of $52.292 billion.

Here is what Carillon Tower Advisers specifically said about McKesson Corporation (NYSE:MCK):

McKesson Corporation (NYSE:MCK) provides diversified insights, products, and services to a variety of participants in the healthcare industry. Most notably, its underlying distribution and specialty services businesses are demonstrating excellent earnings growth, which is no small feat for a company of McKesson’s size. Also, for investors seeking safety, McKesson is currently in a position of considerable financial strength, which should insulate it from substantial economic risks.”

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

kurhan / shutterstock.com

McKesson Corporation (NYSE:MCK) is not on the list of 30 Most Popular Stocks Among Hedge Funds. McKesson Corporation (NYSE:MCK) was held by 47 hedge fund portfolios at the end of the second quarter compared to 59 in the previous quarter.

We discussed McKesson Corporation (NYSE:MCK) in another article and shared Baron Funds’ views on the company. You can check out our hedge fund investor letters Q2 2022 page for more investor letters from hedge funds and other prominent investors.

Disclosure: None. This article is originally published at Insider Monkey.